UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037715
Receipt number R000043015
Scientific Title The safety and efficacy of AZM eye drops on MGD
Date of disclosure of the study information 2019/09/09
Last modified on 2019/08/17 13:28:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The safety and efficacy of azimycin 1% eye drops on patients with posterior blepharitis

Acronym

The efficacy of azimycin eye drops on patients with posterior blepharitis

Scientific Title

The safety and efficacy of AZM eye drops on MGD

Scientific Title:Acronym

The efficacy of AZM eye drops on MGD

Region

Japan


Condition

Condition

posterior blepharitis

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and efficacy of AZM eye drops on patients with meibomian gland dysfunction (MGD) (posterior blepharitis)

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Ocular symptom, lid margin abnormalities, tear film breakup time, lipid layer thickness, non-invasive tear film breakup time, tear osmolarity, meiboscore

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

azimycin eyed drop plus warming eyelid

Interventions/Control_2

warming eyelids

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) 18 years old older
2) both gender
3) informed consent available
4) those who were diagnosed with obstructive MGD
5) those who were diagnosed with seborrheic MGD
6) Ocular symptoms
7) lid margin abnormalities
8) plugging

Key exclusion criteria

1) Stevens-Johnson syndrome
2) acute inflammation
3) lid margin abnormalities
4) allergy
5) CL wear
6) Ocular surgery history within 3 monmths
7) systemic dieseases which might interfere with tear function
8) inappropriate charater
9) ocular diseases except cataract and/or refractive error

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Reiko
Middle name
Last name Arita

Organization

Itoh Clinic

Division name

Ophthalmology

Zip code

3370042

Address

Saitama City

TEL

0486865588

Email

ritoh@za2.so-net.ne.jp


Public contact

Name of contact person

1st name Reiko
Middle name Arita
Last name Arita

Organization

Itoh Clinic

Division name

Ophthalmology

Zip code

3370042

Address

626-11, Minaminakano, Minuma-ku

TEL

+81486865588

Homepage URL


Email

ritoh@za2.so-net.ne.jp


Sponsor or person

Institute

Itoh Clinic

Institute

Department

Personal name



Funding Source

Organization

Lid and meibomian gland working group

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Itoh Clinic

Address

626-11, Minaminakano, Minuma-ku

Tel

0486865588048

Email

ritoh@za2.so-net.ne.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 09 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2019 Year 08 Month 05 Day

Date of IRB


Anticipated trial start date

2019 Year 09 Month 09 Day

Last follow-up date

2020 Year 12 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 08 Month 17 Day

Last modified on

2019 Year 08 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043015


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name